<div id="readability-page-1"><p>Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report)'s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $26.51 and last traded at $26.02, with a volume of 83139 shares traded. The stock had previously closed at $25.02.</p><div><p><span></span><span>Get <strong>Privia Health Group</strong> alerts:</span></p></div><h2>Analyst Ratings Changes</h2><p>PRVA has been the subject of several recent analyst reports. Barclays raised their target price on Privia Health Group from $21.00 to $22.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Thursday, October 9th. Zacks Research raised Privia Health Group from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, August 19th. Citigroup  reissued an &#34;outperform&#34; rating on shares of Privia Health Group in a research report on Friday, August 29th. Evercore ISI reduced their price objective on Privia Health Group from $30.00 to $28.00 and set an &#34;outperform&#34; rating for the company in a research report on Wednesday, July 9th. Finally, Piper Sandler cut their target price on Privia Health Group from $36.00 to $35.00 and set an &#34;overweight&#34; rating on the stock in a report on Monday, August 11th. Eleven research analysts have rated the stock with a Buy rating, two have assigned  a Hold rating and one  has issued  a Sell rating to the company. According to MarketBeat.com, the company  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $28.91.</p><p><b>Read Our Latest Analysis on PRVA</b></p><h2>Privia Health Group Stock Performance</h2><p>The stock's 50-day moving average is $24.10 and its 200 day moving average is $22.76. The firm has a market cap of $3.18 billion, a P/E ratio of 236.70, a PEG ratio of 3.37 and a beta of 0.83. </p><p>Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. On average, research analysts anticipate that  Privia Health Group, Inc. will post 0.14 EPS for the current year. </p><h2>Institutional Investors Weigh In On Privia Health Group</h2><p>Several hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC increased its stake in  Privia Health Group by 37.4% in the third quarter. Smartleaf Asset Management LLC now owns 12,398 shares of the company's stock valued at $303,000 after acquiring an additional 3,373 shares during the last quarter.  Van Berkom &amp; Associates Inc. raised its holdings in shares of  Privia Health Group by 30.1% during the third quarter. Van Berkom &amp; Associates Inc. now owns 3,774,565 shares of the company's stock valued at $93,987,000 after purchasing an additional 873,344 shares during the period.  Thrivent Financial for Lutherans raised its holdings in shares of  Privia Health Group by 8.0% during the third quarter. Thrivent Financial for Lutherans now owns 83,229 shares of the company's stock valued at $2,072,000 after purchasing an additional 6,130 shares during the period.  Arizona State Retirement System increased its position in shares of  Privia Health Group by 1.9% during the third quarter. Arizona State Retirement System now owns 28,835 shares of the company's stock worth $718,000 after acquiring an additional 524 shares in the last quarter.  Finally, Summit Global Investments grew its position in  Privia Health Group by 273.9% in the 3rd quarter. Summit Global Investments now owns 33,677 shares of the company's stock worth $839,000 after purchasing an additional 24,670 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds. </p><h2>About Privia Health Group</h2> (Get Free Report)<p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p><h2>See Also</h2><ul><li>Five stocks we like better than Privia Health Group</li><li>Investing in the High PE Growth Stocks </li><li>Dutch Bros Beats Earnings for 11th Consecutive Quarter</li><li>Stock Average Calculator      </li><li>From Dividends to Growth: Why These 3 Stocks Stand Out in 2025</li><li>Stock Sentiment Analysis: How it Works</li><li>AMD’s Price Pullback Equals Opportunity: The Big Gains Are Coming</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2><p>Before you consider Privia Health Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p><p>While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

PRVA

<p>Privia Health Group (NASDAQ:PRVA) reached a new 52-week high of $26.51, closing at $26.02 with a trading volume of 83,139 shares. Analysts have mixed ratings, with Barclays raising the target price to $22.00 and Zacks upgrading to a 'hold'. The stock has a consensus rating of 'Moderate Buy' and a target price of $28.91. Institutional investors own 94.48% of the stock. The company reported $0.10 EPS and $213.61 million in revenue for the last quarter.</p>

Privia Health Group (NASDAQ:PRVA) Hits New 12-Month High - Should You Buy?